Description
INDUSTRY INNOVATES, PRESENTED BY TELIX: 18F -FET PET/MR IMAGING – REAL WORLD EXPERIENCE IN BRAIN TUMOR PATIENTS
Description
Program Description:
• Understand the limitations of conventional imaging and the unmet imaging needs for brain tumors.
• Recognize the unique mechanism of action and accuracy of amino acid radiotracers for PET/CT brain imaging.
• Understand the real-world experience with over 300 brain tumor patients imaged with FET PET in the United States.
• Realize appropriate use cases through a review of cases and the impact of imaging on clinical decisions.
• Understand the limitations of conventional imaging and the unmet imaging needs for brain tumors.
• Recognize the unique mechanism of action and accuracy of amino acid radiotracers for PET/CT brain imaging.
• Understand the real-world experience with over 300 brain tumor patients imaged with FET PET in the United States.
• Realize appropriate use cases through a review of cases and the impact of imaging on clinical decisions.
Instructions for Participation
THIS IS A NON-CME ACTIVITY & CERTIFICATES WILL NOT BE PROVIDED. To complete this activity, learners will view the webinar session (either during the live presentation or the archived recording) and review related resources.
Release Date: 7/10/2024
By enrolling in this activity, you agree to share your contact information with the session planners.
Speakers
Michael Veronesi, MD, PhD, Associate Professor – UW Radiology
Michael Veronesi, MD, PhD, Associate Professor – UW Radiology
Key Takeaways & Objectives
-
• Understand the limitations of conventional imaging and the unmet imaging needs for brain tumors.
• Recognize the unique mechanism of action and accuracy of amino acid radiotracers for PET/CT brain imaging.
• Understand the real-world experience with over 300 brain tumor patients imaged with FET PET in the United States.
• Realize appropriate use cases through a review of cases and the impact of imaging on clinical decisions.